Newsroom

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest U.S. Equity Buffer UCITS ETF 10% - January 26.10.2026 FJAN.LN IE000MDKBOB3  150,002.00 USD   4,456,077.59   29.707  ...

BOSTON--(BUSINESS WIRE)--HarbourVest Partners, a global private markets asset manager, today announced the appointment of Peter Larsen as Managing Director and Head of Infrastructure Distribution. The appointment reflects the growth of HarbourVest’s infrastructure platform as investors increasingly look to diversify their private markets portfolios with non-correlated offerings. Peter spent more than 17 years at Hamilton Lane in both investment roles and, more recently, as Managing Director, Re...

NEW YORK--(BUSINESS WIRE)--NextGen Healthcare, a leading provider of innovative, cloud-based healthcare technology solutions, has been named to Forbes’ list of America’s Dream Employers 2027.America’s Dream Employers 2027 were determined based on an independent survey of college students as well as employees working over the last three years for companies and institutions employing at least 1,000 employees in the U.S. Over 266,000 data points were gathered from organizations across all industry...

PALO ALTO, Calif.--(BUSINESS WIRE)--D-Wave Quantum Inc. (NASDAQ: QBTS) (“D-Wave” or the “Company”), the only dual-platform quantum computing company providing both annealing and gate-model systems, software and services, today announced it will release its financial results for the third quarter of 2026 ended September 30, 2026 on Tuesday, November 10, 2026 before market open. The press release will be available on the D-Wave Investor Relations website: ir.dwavequantum.com. In conjunction with...

ROCHESTER, N.Y.--(BUSINESS WIRE)--Eastman Kodak Company Third-Quarter 2026 Earnings Conference Call...

AMSTERDAM--(BUSINESS WIRE)--Avanzanite Bioscience B.V., azienda farmaceutica europea specializzata in malattie rare, oggi ha annunciato l'espansione della sua presenza nel Regno Unito (UK) e la nomina di Sarah O’Connell a UK Country Manager. L'iniziativa rafforza l'impegno a lungo termine di Avanzanite in UK e la sua capacità di aiutare i pazienti idonei ad accedere a farmaci innovativi per malattie rare. “Il Regno Unito è essenziale per la nostra ambizione di sviluppare Avanzanite in un'aziend...

AMSTERDAM--(BUSINESS WIRE)--Avanzanite Bioscience B.V., een Europees farmaceuticabedrijf dat zich op zeldzame ziekten richt, kondigde vandaag de uitbreiding van zijn aanwezigheid in de UK (United Kingdom) aan, alsook de benoeming van Sarah O’Connell tot UK Country Manager. Deze zet verstevigt de langetermijnverbintenis van Avanzanite met de UK en het vermogen van het bedrijf om hulp te bieden aan patiënten die in aanmerking komen om toegang te krijgen tot innovatieve geneesmiddelen voor zeldzam...

ÁMSTERDAM--(BUSINESS WIRE)--Avanzanite Bioscience B.V., una empresa farmacéutica europea especializada en enfermedades raras, ha anunciado hoy la ampliación de su presencia en el Reino Unido y el nombramiento de Sarah O’Connell como directora nacional para el Reino Unido. Esta medida refuerza el compromiso a largo plazo de Avanzanite con el Reino Unido y su capacidad para ayudar a los pacientes que cumplan los requisitos a acceder a medicamentos innovadores para enfermedades raras. «El Reino Un...

PORTLAND, Maine--(BUSINESS WIRE)--WEX® (NYSE: WEX), a global leader in intelligent payment solutions, and Euclid AI, the leading provider of agentic AI solutions for asset-based trucking, today announced an agreement to bring AI agents to WEX over-the-road (OTR) customers. Through the agreement, WEX and Euclid AI will work jointly to help WEX customers save time and money by embedding agentic AI at scale across their businesses. AI has become a business imperative for fleet operators. Carriers...

AMSTERDAM--(BUSINESS WIRE)--Avanzanite Bioscience B.V., ein europäisches Pharmaunternehmen, das sich auf seltene Krankheiten spezialisiert hat, gab heute die Erweiterung seiner Präsenz im Vereinigten Königreich (UK) sowie die Ernennung von Sarah O’Connell zur Managerin für das Land bekannt. Dieser Schritt zeigt das langfristige Interesse des Unternehmens an dieser Region und ermöglicht betroffenen Patienten den Zugang zu innovativen Medikamenten für seltene Krankheiten. „Großbritannien ist für...